Science Explorer Interactive view Map
Company · Zug · Switzerland

Amgen (Switzerland)

In research, Amgen (Switzerland) stands highest in Medicine (#10,413 of 17,978 worldwide) and Health Sciences (#13,318 of 20,462 worldwide), over all time.

World rank, all time
#23,419
of 42,892
Rank in Switzerland
#230
of 429
Research works
273
▼ 6% vs 2013–17
Citations
4.2k
15.4 per fractional work
Top-10% rate
16.7%
record average 16.5%
Open access
44%
world 28%

What is Amgen (Switzerland) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #10,413 of 17,978 15.9%153
Health SciencesDomain #13,318 of 20,462 16.0%159

Each strip is that field’s whole ranked pool, with the notch where Amgen (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.31× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.03× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.52× its world share, 2 worksImmunology and Micro…Neuroscience: 0.68× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.45× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.27× its world share, 0 worksChemistryComputer Science: 0.24× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.35× its world share, 0 worksEarth and Planetary …Engineering: 0.31× its world share, 2 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.18× its world share, 0 worksMaterials ScienceMathematics: 1.20× its world share, 1 worksMathematicsPhysics and Astronomy: 0.70× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 2.14× its world share, 19 worksMedicineArts and Humanities: 0.19× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 2.47× its world share, 4 worksBusiness, Management…Decision Sciences: 0.38× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 8.58× its world share, 8 worksEconomics, Econometr…Social Sciences: 0.53× its world share, 3 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 8.6×. Every wedge is a field page.

Who are the top researchers at Amgen (Switzerland)?

Ranked on the composite score, Mickael Löthgren, Guillermo Villa and Guy Hechmati lead among researchers whose main affiliation is Amgen (Switzerland).

  1. 1 Mickael Löthgren Switzerland · #354,639 worldwide 80 citations · 23 works
  2. 2 Guillermo Villa Switzerland · #904,038 worldwide 19 citations · 23 works
  3. 3 Guy Hechmati Switzerland · #1,555,172 worldwide 12 citations · 15 works
  4. 4 Lucie Kutikova Switzerland · #1,566,907 worldwide 4 citations · 15 works
All ranked researchers at Amgen (Switzerland)

Which keywords describe research at Amgen (Switzerland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Cardiovascular Disease Prevention, Genetic Variants, Targeted Therapy, Financial Stability, C-Reactive Protein, Statins and Cholesterol-lowering.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Clinical Trials6▲ 19×7 topics
  2. Cardiovascular Disease Prevention3▲ 76×2 topics
  3. Quality of Life3▲ 4.4×6 topics
  4. Genetic Variants3▲ 36×3 topics
  5. C-Reactive Protein3▲ 79×2 topics
  6. Financial Stability3▲ 29×2 topics
  7. Statins3▲ 79×2 topics
  8. Targeted Therapy3▲ 27×3 topics
  9. Cholesterol-lowering3▲ 129×1 topic
  10. LDL Cholesterol3▲ 168×1 topic
  11. Chemotherapy2▲ 7.5×7 topics
  12. Cost-effectiveness Analysis2▲ 61×1 topic
  13. Health Utility Measures2▲ 61×1 topic
  14. Sustainable Development2▲ 3.2×4 topics
  15. Genomic Profiling2▲ 45×2 topics
  16. ALK Inhibitors2▲ 69×1 topic
  17. EGFR Mutations2▲ 69×1 topic
  18. Treatment Guidelines2▲ 20×2 topics
  19. Investment2▲ 41×2 topics
  20. COVID-192▲ 2.5×2 topics
  21. Inflammation2▲ 1.73×8 topics
  22. Climate Finance2▲ 177×1 topic
  23. Drug Development Costs2▲ 126×1 topic
  24. Generic Drugs2▲ 126×1 topic
  25. Green Bonds2▲ 177×1 topic
  26. Industrial Policy2▲ 30×2 topics
  27. Atherosclerosis1▲ 10×3 topics
  28. Cardiovascular Disease1▲ 2.6×8 topics
  29. Cost of Care1▲ 94×1 topic
  30. Ethical Guidelines1▲ 54×2 topics
  31. European Union1▲ 13×1 topic
  32. Financial Toxicity1▲ 94×1 topic
  33. State Aid1▲ 528×1 topic
  34. Investment Strategies1▲ 177×1 topic
  35. Sovereign Wealth Funds1▲ 223×1 topic
  36. Cytokines1▲ 8.4×2 topics
  37. Molecular Subtypes1▲ 28×2 topics
  38. Regulatory T Cells1▲ 20×2 topics
  39. Bilateral Investment Treaties1▲ 117×1 topic
  40. Foreign Direct Investment1▲ 45×1 topic

Which research topics does Amgen (Switzerland) publish most on?

By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Lung Cancer Treatments and Mutations and Sustainable Finance and Green Bonds.

  1. 1 Lipoproteins and Cardiovascular Health Surgery 3 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  4. 4 Sustainable Finance and Green Bonds Finance 2 works
  5. 5 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  7. 7 EU Law and Policy Analysis Law 1 works
  8. 8 State Capitalism and Financial Governance Strategy and Management 1 works
  9. 9 International Arbitration and Investment Law Strategy and Management 1 works
  10. 10 Colorectal Cancer Treatments and Studies Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.3%not open55.7%

World: 28% of research is openly available.

with international co-authors77.1%domestic only22.9%

World: 19% is written across borders.

How has Amgen (Switzerland)'s research output changed?

Output in 2018–2022 was 6% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Zug

All research institutions in Zug

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.